Clinical Trials Browser

Expanded_access × Ovarian Neoplasms × niraparib × Clear all

NCT03025867 2017-04-17

Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer

Approved for marketing

Ovarian Neoplasms